Table 1

Numbers and indications for growth hormone (GH) therapy

Code Diagnosis Total no. Rx % males Age range (median) % of total
GH Rx
Licensed indications (78%)
GH deficiency (55%)
1 Idiopathic growth hormone deficiency65668%0.3–15.9  (11.5)27%
2 Congenital growth hormone deficiency (e.g. septo-optic dysplasia)22561%0.7–15.9 (8.4)9%
3 Craniopharyngioma9158%2.8–15.9 (12.2)4%
4 Other acquired growth hormone deficiency (e.g. post-irradiation)34757%0.5–15.9 (12.5)14%
5Turner syndrome4770%2.4–15.9 (11.3)20%
6Renal disease6368%3.0–15.9 (10.3)3%
Unlicensed indications (22%)
7Intrauterine growth retardation7467%2.3–15.6 (10.7)3%
8Noonan syndrome4468%7.0–15.9 (12.2)2%
9Bony dysplasia10755%2.7–15.8 (11.5)4%
10All others31161%0.5–15.9 (11.9)13%
Total2395100%